A Phase 1 placebo-controlled, randomized, double-blind combined single and multiple ascending dose study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of RO5271983 in healthy subjects

Trial Profile

A Phase 1 placebo-controlled, randomized, double-blind combined single and multiple ascending dose study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of RO5271983 in healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Jun 2016

At a glance

  • Drugs RG 7185 (Primary)
  • Indications Asthma
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Roche
  • Most Recent Events

    • 17 Jan 2012 Actual end date changed from May 2011 to Dec 2011 as reported by ClinicalTrials.gov.
    • 05 Dec 2011 Actual patient number is 82 according to ClinicalTrials.gov.
    • 05 Dec 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top